Trial intelligence / Profile preview

Standard Nutrition Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma

NCT04436965Phase 3Recruiting

Sponsor
Sun Yat-sen University
Start
Aug 2021
Primary completion
Dec 2026
Countries
1
01

Overview

Phase 3, randomised, open-label trial (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Incidence of Ideal Body Weight Percentage at 2 months. Started Aug 2021; status: recruiting.

Beyond the preview

Go deeper on NCT04436965.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04436965.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call